Original Source(s)
Related Content
Investigational Drug Shows Potentialin Phase 3 Obesity Trial
In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.
June 10, 2026
-
4 min
Side Effects: The Body Keeps Score
Turns out biology tracks more than we thought — from a spit test that reads your all-nighter to a surgical outcome that still shows up in household chores two decades later. Plus: habits aren't built gradually. They snap.
by Kerri Miller
June 4, 2026
-
5 min
The Mental Health Gap Doctors Don’t Close
National survey data also suggested lower treatment rates among health care workers with either condition.
by Kerri Miller
May 27, 2026
-
5 min
